Martin Berg Johansen
Overview
Explore the profile of Martin Berg Johansen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
768
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Linauskas A, Overvad K, Johansen M, Stengaard-Pedersen K, de Thurah A
Clin Epidemiol
. 2018 Dec;
10:1709-1720.
PMID: 30538575
Purposes: To assess whether the positive predictive value (PPV) of first-time rheumatoid arthritis (RA) diagnosis registration in the Danish National Patient Registry increases when data are linked to the RA...
12.
Tram L, Veno S, Dahm C, H Thomsen B, Johansen M, Overvad K, et al.
Nutrients
. 2018 Oct;
10(11).
PMID: 30360550
Diet may influence the risk of ischemic stroke by several mechanisms. A potential and hitherto unknown mechanism may relate to an effect on the lipophilic index, which is a new...
13.
Joensen A, Joergensen T, Lundbye-Christensen S, Johansen M, Guzman-Castillo M, Bandosz P, et al.
PLoS One
. 2018 Apr;
13(4):e0194793.
PMID: 29672537
Aim: To quantify the contribution of changes in different risk factors population levels and treatment uptake on the decline in CHD mortality in Denmark from 1991 to 2007 in different...
14.
Johansen M, Christensen P
Clin Chem Lab Med
. 2018 Apr;
56(9):1524-1532.
PMID: 29634477
Background: Definition and elimination of outliers is a key element for medical laboratories establishing or verifying reference intervals (RIs). Especially as inclusion of just a few outlying observations may seriously...
15.
Rasmussen S, Krarup H, Sunesen K, Johansen M, Stender M, Pedersen I, et al.
Oncotarget
. 2018 Feb;
9(6):7010-7022.
PMID: 29467946
Epigenetic alterations in colorectal cancer (CRC) cause important differences in the underlying tumor biology and aggressiveness. DNA hypermethylation is central for the development of CRC but the prognostic impact remains...
16.
Johnsen P, Johansen M, Jensen S
Dan Med J
. 2018 Feb;
65(2).
PMID: 29393035
Ischaemic heart disease (IHD) is the leading cause of mortality in the Western world. Therefore, to focus on those at risk of having IHD while at the same time avoiding...
17.
Attar R, Johansen M, Valentin J, Aagaard J, Jensen S
PLoS One
. 2017 Dec;
12(12):e0189289.
PMID: 29236730
Background: A correlation between excess mortality from myocardial infarctions (MI) and schizophrenia has already been established. What remains unclear is whether the initial communication between the treating doctor and the...
18.
Henriksen S, Madsen P, Larsen A, Johansen M, Pedersen I, Krarup H, et al.
Oncotarget
. 2017 Dec;
8(55):93942-93956.
PMID: 29212200
Introduction: Few prognostic biomarkers are available for pancreatic cancer. The aim of this study is to examine the correlation between the survival of pancreatic adenocarcinoma patients and hypermethylated genes in...
19.
Graversen C, Eichhorst R, Ravn L, Christiansen S, Johansen M, Larsen M
Scand Cardiovasc J
. 2017 Oct;
51(6):316-322.
PMID: 29019280
Aim: Barriers to participation in cardiac rehabilitation (CR) may occur at three levels of the referral process (lack of information, declining to participate, and referral to appropriate CR programme). The...
20.
Henriksen S, Madsen P, Larsen A, Johansen M, Pedersen I, Krarup H, et al.
Int J Cancer
. 2017 Sep;
141(12):2489-2497.
PMID: 28857158
Correct staging of pancreatic cancer is paramount, as treatment is stage specific. However, minimally invasive tools to facilitate staging are lacking. DNA promoter hypermethylation is a hallmark of cancer. The...